About
Physical Characteristics
Caps:
Ovate to campanulate, 1-3 cm wide, light yellow, bruising deep blue when touched
Gills:
Adnate, initially grayish, becoming purplish-black with age
Psychoactive Effects
Euphoric
Describing intense feelings of happiness or excitement
Perceptual
The change in the way things are perceived, including changes in time perception, spatial perception, and perception of one's own body.
Visuals
TTBVI and Pan Cyan species have a reputation for seeing intensly vivid and colorful patterns, shapes, and objects. TTBVI is typically found to be more potent than general Pan Cyan and therefore can induce a more intense experience.
Helps With
Depression
Relieves symptoms of depression, improving mood and outlook
Anxiety
Helps to alleviate feelings of worry, fear, and unease
Addiction
Helps to overcome addiction and substance abuse
PTSD
Helps to alleviate symptoms of post-traumatic stress disorder
OCD
Helps to alleviate symptoms of obsessive-compulsive disorder
ADD ADHD
Helps to alleviate symptoms of attention deficit disorder and attention deficit hyperactivity disorder
Pain
Microdosing psilocybin has been shown to help with certain types of pain
Migraines
Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines. A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.
Potential Side Effects
Nausea
A feeling of discomfort in the stomach with an urge to vomit
Medicinal Chemistry
Look Alike Species
Specie: | Differences: | |
---|---|---|
Panaeolus foenisecii Edibility:Psychoactive | P. foenisecii lacks the distinctive blue bruising and light yellow cap color of the BVI strain. |
Specie:
Panaeolus foenisecii
Edibility:
Psychoactive
Differences:P. foenisecii lacks the distinctive blue bruising and light yellow cap color of the BVI strain.
Mushroom Ratings
0.0
Based on 0 Review
5
★4
★3
★2
★1
★Share your thoughts
If you've consumed this mushroom, share your thoughts with our community
References
Psilocybin desynchronizes the human brain
An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus
Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer
Healthy adults were tracked before, during and for 3 weeks after high-dose psilocybin (25 mg) and methylphenidate (40 mg), and brought back for an additional psilocybin dose 6–12 months later. Psilocybin massively disrupted functional connectivity (FC) in cortex and subcortex, acutely causing more than threefold greater change than methylphenidate. These FC changes were driven by brain desynchronization across spatial scales (areal, global), which dissolved network distinctions by reducing correlations within and anticorrelations between networks. Psilocybin-driven FC changes were strongest in the default mode network, which is connected to the anterior hippocampus and is thought to create our sense of space, time and self.
2024
This review discusses species identification, taxonomy and classification, available DNA sequence data and psychedelic species in Psilocybe, Panaeolus, Pluteus, and Gymnopilus, as well as similar looking genera that could be harmful.
2023
This study examines the effects and safety of Panaeolus cyanescens extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.
2020
Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer.
2010